General

Bamlanivimab, Benzinga, Biotech, Coronavirus, COVID-19, General, Health Care, LLY, News, REGN, the National Institute of Allergy and Infectious Diseases, US5324571083, US75886F1075

NIAID Study Finds Eli Lilly’s Antibody Drug Unhelpful For Hospitalized COVID-19 Patients

Eli Lilly and Company (NYSE: LLY) said Monday that a trial of its antibody treatment for use in hospitalized COVID-19 patients has come to an end as the treatment is unlikely to help such patients. 
read more

2020 presidential election, Benzinga, Cannabis, cannabis industry, election day, Exclusives, Financing, General, inflation, Interview, joe biden, kamala harris, marijuana reform, Markets, medical cannabis, Michael Steinmetz, News, small business

Flow Cannabis CEO On Post-Election Policy Hopes, Strategy On Heels Of Caldera Launch

Flow Cannabis Co. recently launched Caldera, a line of premium extracts, vape cartridges, oils, and concentrates defined by their purity, potency and flavor.
read more

1 2 3 161